inovacinė firma MKDS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,660,645 | 2,991,592 | 3,497,823 | 4,048,777 | 4,682,133 | 5,146,892 | 5,346,339 | 6,534,180 |
| Profit before tax | 244,402 | 514,460 | 1,033,709 | 1,195,417 | 1,363,283 | 1,360,509 | 1,444,860 | 1,572,377 |
| Net profit | 226,320 | 458,527 | 884,852 | 1,040,913 | 1,172,199 | 1,155,653 | 1,229,181 | 1,334,235 |
| Equity | 3,624,083 | 4,082,610 | 4,967,462 | 5,040,251 | 6,212,450 | 7,368,103 | 8,597,284 | 9,931,519 |
| Liabilities | 1,684,238 | 1,378,169 | 1,094,646 | 1,297,054 | 925,370 | 1,010,215 | 1,143,361 | 1,238,872 |
| Non-current assets | 2,709,930 | 2,417,279 | 2,624,579 | 1,815,653 | 1,615,329 | 2,934,800 | 3,283,653 | 3,112,464 |
| Current assets | 2,629,919 | 3,043,500 | 3,437,529 | 4,521,652 | 5,522,491 | 5,443,518 | 6,456,992 | 8,081,125 |
| Total assets | 5,339,849 | 5,460,779 | 6,062,108 | 6,337,305 | 7,137,820 | 8,378,318 | 9,740,645 | 11,193,589 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 852,720 | 832,069 | 1,228,758 |
| Social insurance contributions | - | - | - | - | - | 89,493 | 102,548 | 130,842 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +34.9% | +12.4% | +16.9% | +15.8% | +15.6% | +9.9% | +3.9% | +22.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.2% | 8.4% | 14.6% | 16.4% | 16.4% | 13.8% | 12.6% | 11.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 6.2% | 11.2% | 17.8% | 20.7% | 18.9% | 15.7% | 14.3% | 13.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.5% | 15.3% | 25.3% | 25.7% | 25.0% | 22.5% | 23.0% | 20.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 9.2% | 17.2% | 29.6% | 29.5% | 29.1% | 26.4% | 27.0% | 24.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.3 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 113,622 | 109,449 | 143,255 | 149,035 | 183,613 | 255,217 | 252,583 | 281,040 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
inovacinė firma MKDS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-26 | 0.39 |
| 2026-01-22 | 2026-02-04 | 0.39 |
| 2026-01-21 | 2026-01-21 | 12.89 |
| 2025-11-18 | 2025-11-19 | 39.05 |
| 2025-10-16 | 2025-10-19 | 9889.94 |
| 2025-02-18 | 2025-02-20 | 84.06 |
| 2025-02-10 | 2025-02-10 | 0.45 |
| 2025-01-22 | 2025-02-05 | 0.45 |
| 2024-10-16 | 2024-10-23 | 172.65 |
inovacinė firma MKDS - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company inovacinė firma MKDS is: 37 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 37.21 |
| 2026-07-01 | 2026-07-07 | 67552.15 |
| 2026-06-28 | 2026-06-30 | 67279.6 |
| 2025-11-02 | 2025-11-02 | 46239.85 |
| 2025-10-30 | 2025-11-01 | 46191.81 |
| 2025-03-06 | 2025-03-06 | 3276.82 |
| 2025-01-22 | 2025-01-27 | 0.56 |
| 2025-01-01 | 2025-01-21 | 518.14 |
| 2024-12-30 | 2024-12-31 | 517.58 |
| 2024-12-28 | 2024-12-29 | 5.93 |
| 2024-12-24 | 2024-12-27 | 877.58 |
| 2024-12-19 | 2024-12-23 | 871.65 |
| 2024-12-18 | 2024-12-18 | 204.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MKDS, UAB (code 120427320) is a Private Limited Liability Company engaged in the wholesale of agrochemical products and fertilisers. In 2025, the company generated revenue of EUR 6.53 million, up 22.2% year on year and 26.9% over two years. Net profit increased to EUR 1.33 million in 2025 from EUR 1.23 million in 2024 and EUR 1.16 million in 2023, while the profit margin remained solid at 20.4% after 23.0% in 2024 and 22.5% in 2023. Balance sheet size expanded to EUR 11.19 million in 2025 from EUR 9.74 million in 2024 and EUR 8.38 million in 2023. Equity rose to EUR 9.93 million, with liabilities of EUR 1.24 million, leaving a strong equity ratio of 88.7% and debt to equity of 0.12. Asset turnover stood at 0.58x, ROE at 13.4% and ROA at 11.9% in 2025. Revenue per employee was EUR 284.1K and profit per employee was EUR 58.0K, indicating efficient operations.